RxSight, Inc. Capital Expenditures
RxSight, Inc. (RXST) reported Capital Expenditures of $2.71 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-05
- RxSight, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $1.96M, a 27.26% increase year-over-year.
- RxSight, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $759.00K, a 32.00% increase year-over-year.
- RxSight, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $1.14M, a 34.24% increase year-over-year.
- RxSight, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $581.00K, a 47.33% decline year-over-year.
- RxSight, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $3.83M, a 29.60% decline from fiscal 2024.
- RxSight, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $5.44M, a 13.00% increase from fiscal 2023.
- RxSight, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $4.81M, a 101.17% increase from fiscal 2022.
- RxSight, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $2.39M, a 23.35% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $2.71M 10-Q · filed 2026-08-05 | $3.85M derived: sum of 3 quarters · filed 2026-08-05 | $4.43M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $759.00K 10-Q · filed 2026-05-06 | $1.90M derived: sum of 2 quarters · filed 2026-05-06 | $2.48M derived: sum of 3 quarters · filed 2026-05-06 | $4.01M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $1.72M derived: sum of 2 quarters · filed 2026-02-25 | $3.25M derived: sum of 3 quarters · filed 2026-08-05 | $3.83M 10-K · filed 2026-02-25 |
| 2025-09-30 | $581.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $2.12M derived: sum of 2 quarters · filed 2026-08-05 | $2.69M 10-Q · filed 2025-11-05 | $3.54M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $1.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $2.11M 10-Q · filed 2026-08-05 | $2.96M derived: sum of 3 quarters · filed 2026-08-05 | $4.06M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $575.00K 10-Q · filed 2026-05-06 | $1.42M derived: sum of 2 quarters · filed 2026-05-06 | $2.52M derived: sum of 3 quarters · filed 2026-05-06 | $4.05M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $847.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $1.95M derived: sum of 2 quarters · filed 2026-02-25 | $3.47M derived: sum of 3 quarters · filed 2026-02-25 | $5.44M 10-K · filed 2026-02-25 |
| 2024-09-30 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $2.63M derived: sum of 2 quarters · filed 2025-11-05 | $4.59M 10-Q · filed 2025-11-05 | $6.18M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $1.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $3.49M 10-Q · filed 2025-08-07 | $5.08M derived: sum of 3 quarters · filed 2026-02-25 | $5.73M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $1.97M 10-Q · filed 2025-05-07 | $3.56M derived: sum of 2 quarters · filed 2026-02-25 | $4.21M derived: sum of 3 quarters · filed 2026-02-25 | $6.03M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $1.59M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $2.24M derived: sum of 2 quarters · filed 2026-02-25 | $4.07M derived: sum of 3 quarters · filed 2026-02-25 | $4.81M 10-K · filed 2026-02-25 |
| 2023-09-30 | $653.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $2.48M derived: sum of 2 quarters · filed 2024-11-07 | $3.22M 10-Q · filed 2024-11-07 | $3.58M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $1.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $2.57M 10-Q · filed 2024-08-05 | $2.93M derived: sum of 3 quarters · filed 2025-02-25 | $3.51M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $747.00K 10-Q · filed 2024-05-06 | $1.11M derived: sum of 2 quarters · filed 2025-02-25 | $1.69M derived: sum of 3 quarters · filed 2025-02-25 | $2.77M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $362.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $942.00K derived: sum of 2 quarters · filed 2025-02-25 | $2.02M derived: sum of 3 quarters · filed 2025-02-25 | $2.39M 10-K · filed 2025-02-25 |
| 2022-09-30 | $580.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $1.66M derived: sum of 2 quarters · filed 2023-11-09 | $2.03M 10-Q · filed 2023-11-09 | $2.40M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $1.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $1.45M 10-Q · filed 2023-08-07 | $1.82M derived: sum of 3 quarters · filed 2023-08-07 | $2.07M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $370.00K 10-Q · filed 2023-05-09 | $735.00K derived: sum of 2 quarters · filed 2023-05-09 | $989.00K derived: sum of 3 quarters · filed 2023-05-09 | $1.81M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $365.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $619.00K derived: sum of 2 quarters · filed 2023-03-06 | $1.44M derived: sum of 3 quarters · filed 2023-03-06 | $1.94M 10-K · filed 2023-03-06 |
| 2021-09-30 | $254.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $1.08M derived: sum of 2 quarters · filed 2022-11-07 | $1.57M 10-Q · filed 2022-11-07 | $2.11M derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-06-30 | $823.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $1.32M 10-Q · filed 2022-08-08 | $1.86M derived: sum of 3 quarters · filed 2022-08-08 | $2.46M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $498.00K 10-Q · filed 2022-05-05 | $1.04M derived: sum of 2 quarters · filed 2022-05-05 | $1.64M derived: sum of 3 quarters · filed 2022-05-05 | |
| 2020-12-31 | $538.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $1.14M derived: sum of 2 quarters · filed 2022-03-08 | $2.54M 10-K · filed 2022-03-08 | |
| 2020-09-30 | $603.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $2.00M 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $1.40M 10-Q · filed 2021-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |